SCHEMBL1917064

SCHEMBL1917064

CCCn1c(-c2ccccc2)nc(C)c1CN(Cc1cccc(OCC)c1)C(C)c1ccc2c(c1)OCCO2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.38
ALDH1A1 P00352 3/20 0.34
MAPK1 P28482 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
MAPT P10636 2/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
CXCR3 P49682 4/20 0.34
MAOA P21397 4/20 0.33
MAOB P27338 4/20 0.33
USP2 O75604 1/20 0.33
ALPG P10696 1/20 0.33
METAP2 P50579 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL650089 0.93 C5AR1 (0.37) C5AR1ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL5634119 0.89 C5AR1 (0.43) C5AR1ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL651171 0.88 C5AR1 (0.42) C5AR1ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL649431 0.86 C5AR1 (0.44) C5AR1ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL648187 0.82 C5AR1 (0.46) C5AR1ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL650859 0.81 C5AR1 (0.51) C5AR1ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL649494 0.79 C5AR1 (0.44) C5AR1ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL650039 0.79 C5AR1 (0.49) C5AR1ALDH1A1MAPK1OPRM1OPRD1
SCHEMBL1913077 0.78 CXCR3 (0.33) ALDH1A1MAPK1OPRM1OPRD1SMN1; SMN2
SCHEMBL651442 0.78 C5AR1 (0.47) C5AR1ALDH1A1MAPK1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed